BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35353644)

  • 1. Severe headache trajectory following aneurysmal subarachnoid hemorrhage: the association with lower sodium levels.
    Eisinger RS; Sorrentino ZA; Lucke-Wold B; Zhou S; Barlow B; Hoh B; Maciel CB; Busl KM
    Brain Inj; 2022 Mar; 36(4):579-585. PubMed ID: 35353644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in opioid and analgesic use for headaches after aneurysmal subarachnoid hemorrhage over time.
    Viswanathan V; Lucke-Wold B; Jones C; Aiello G; Li Y; Ayala A; Fox WC; Maciel CB; Busl KM
    Neurochirurgie; 2021 Sep; 67(5):427-432. PubMed ID: 33771620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal Relationship between Hyponatremia and Development of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage Patients: A Retrospective Observational Study.
    Escamilla-Ocañas CE; Venkatasubba Rao CP; Bershad E; Damani R
    J Stroke Cerebrovasc Dis; 2020 Jun; 29(6):104789. PubMed ID: 32205028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Course of Headache in Patients With Moderate-to-Severe Headache Due to Aneurysmal Subarachnoid Hemorrhage: A Retrospective Cross-Sectional Study.
    Hong CK; Joo JY; Kim YB; Shim YS; Lim YC; Shin YS; Chung J
    Headache; 2015; 55(7):992-9. PubMed ID: 26129830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Alkaline Phosphatase Level is Associated with Angiographic Vasospasm, Delayed Cerebral Ischemia-Caused Clinical Deterioration, and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage.
    Zhu Y; Jiang H; Li Y; Weng Y; Xu K; Zhou L; Lin H; Sun T; Cheng D; Shen J; Zeng J; Ye D; Wang D; Zhan R
    Neurocrit Care; 2019 Dec; 31(3):466-475. PubMed ID: 31016639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium Variability and Probability of Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage.
    Chua MMJ; Enríquez-Marulanda A; Gomez-Paz S; Akamatsu Y; Salem MM; Maragkos GA; Ascanio LC; Hanafy KA; Fehnel CR; Ogilvy CS; Moore J; Thomas AJ
    J Stroke Cerebrovasc Dis; 2022 Jan; 31(1):106186. PubMed ID: 34749298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating reversible cerebral vasoconstriction syndrome with subarachnoid hemorrhage from other causes of subarachnoid hemorrhage.
    Muehlschlegel S; Kursun O; Topcuoglu MA; Fok J; Singhal AB
    JAMA Neurol; 2013 Oct; 70(10):1254-60. PubMed ID: 23939614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of fluctuations in serum sodium levels following aneurysmal subarachnoid hemorrhage: an exploratory analysis.
    Eagles ME; Tso MK; Macdonald RL
    J Neurosurg; 2018 Aug; 131(2):420-425. PubMed ID: 30117765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of early mobilization and rehabilitation on complications in aneurysmal subarachnoid hemorrhage.
    Karic T; Røe C; Nordenmark TH; Becker F; Sorteberg W; Sorteberg A
    J Neurosurg; 2017 Feb; 126(2):518-526. PubMed ID: 27058204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early permanent cerebrospinal fluid diversion in aneurysmal subarachnoid hemorrhage: does a lower rate of nosocomial meningitis outweigh the risk of delayed cerebral vasospasm related morbidity?
    Croci DM; Dalolio M; Aghlmandi S; Taub E; Rychen J; Chiappini A; Zumofen D; Guzman R; Mariani L; Roethlisberger M
    Neurol Res; 2021 Jan; 43(1):40-53. PubMed ID: 33106124
    [No Abstract]   [Full Text] [Related]  

  • 11. Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study.
    McGirt MJ; Garces Ambrossi GL; Huang J; Tamargo RJ
    J Neurosurg; 2009 May; 110(5):968-74. PubMed ID: 19199459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration and characteristics of persistent headache following aneurysmal subarachnoid hemorrhage.
    Gaastra B; Carmichael H; Galea I; Bulters D
    Headache; 2022 Nov; 62(10):1376-1382. PubMed ID: 36426750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Variability and Trajectories of DNA Methylation May Support a Role for HAMP in Patient Outcomes After Aneurysmal Subarachnoid Hemorrhage.
    Heinsberg LW; Arockiaraj AI; Crago EA; Ren D; Shaffer JR; Sherwood PR; Sereika SM; Weeks DE; Conley YP
    Neurocrit Care; 2020 Apr; 32(2):550-563. PubMed ID: 31346934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine use is an independent risk factor for cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Conway JE; Tamargo RJ
    Stroke; 2001 Oct; 32(10):2338-43. PubMed ID: 11588323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between endothelin polymorphisms and aneurysmal subarachnoid hemorrhage, clinical vasospasm, delayed cerebral ischemia, and functional outcome.
    Griessenauer CJ; Starke RM; Foreman PM; Hendrix P; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Pittet JF; Mathru M
    J Neurosurg; 2018 May; 128(5):1311-1317. PubMed ID: 28548598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity of cerebral vasospasm associated with development of collaterals following aneurysmal subarachnoid hemorrhage.
    Al-Mufti F; Witsch J; Manning N; Crimmins M; Amuluru K; Agarwal S; Park S; Willey JZ; Kamel H; Connolly ES; Meyers PM; Claassen J
    J Neurointerv Surg; 2018 Jul; 10(7):638-643. PubMed ID: 29760013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain Assessment Following Opioid Administration in Aneurysmal Subarachnoid Hemorrhage Associated Headache.
    Bui VT; Pfeifer C; Snelgrove DK; Neyens RR
    J Pharm Pract; 2024 Apr; ():8971900241248481. PubMed ID: 38627957
    [No Abstract]   [Full Text] [Related]  

  • 18. Headache persisting after aneurysmal subarachnoid hemorrhage: A narrative review of pathophysiology and therapeutic strategies.
    Sorrentino ZA; Laurent D; Hernandez J; Davidson C; Small C; Dodd W; Lucke-Wold B
    Headache; 2022 Oct; 62(9):1120-1132. PubMed ID: 36112096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications.
    Chaudhry SR; Stoffel-Wagner B; Kinfe TM; Güresir E; Vatter H; Dietrich D; Lamprecht A; Muhammad S
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194369
    [No Abstract]   [Full Text] [Related]  

  • 20. The burden of headache following aneurysmal subarachnoid hemorrhage: a prospective single-center cross-sectional analysis.
    Huckhagel T; Klinger R; Schmidt NO; Regelsberger J; Westphal M; Czorlich P
    Acta Neurochir (Wien); 2020 Apr; 162(4):893-903. PubMed ID: 32016589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.